Skip to main content
SpringerLink
Log in

Hematologic Support of the Patient with Malignancy

  • Chapter
Cancer Management in Man

Part of the book series: Cancer Growth and Progression ((CAGP,volume 10))

  • 163 Accesses

Abstract

Patients with malignancy frequently develop significant degrees of compromised bone marrow function and increased loss and utilization of the formed elements of the blood as a consequence of the disease process. Surgical therapy frequently results in the external loss of blood components and significant suppression of bone marrow function occurs as the result of medical therapy for the malignancy. The availability of hematologic supportive therapy in the form of transfusion of blood products has, over the past several years, in conjunction with overall improved medical support, made it possible to deliver more effective antitumor therapy and palliative support to these patients. Modern transfusion techniques and practices now provide effective temporizing measures for use during the treatment of patients with a wide variety of malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramson N, Eisenberg PD, Aster RH: Post-transfusion purpura: immunologic aspects and therapy. N Engl J Med 291:1163, 1974

    Article  PubMed  CAS  Google Scholar 

  2. Adamson J, Hilman RD: Blood volume and plasma protein replacement following acute blood loss in man. JA MA 205:63, 1968

    Google Scholar 

  3. Alavi JB, Root RK, Djerassi I, Evans AE, Gluckman SJ, MacGregor RR, Guerry D, Schreiber AD, Shaw JM, Koch P, Cooper RA: A randomized clinical trial of granulocyte transfusions for infection of acute leukemia. N Engl J Med 296:706, 1977

    Article  PubMed  CAS  Google Scholar 

  4. Barton JC: Non hemolytic, non infectious transfusion reactions. Seminars in Hematology 18:95,1981

    PubMed  CAS  Google Scholar 

  5. Betzhold J, Hong R: Fatal graft-versus-host disease after a small leukocyte transfusion in a patient with lymphoma and varicella. Pediatrics 62:63, 1978.

    PubMed  CAS  Google Scholar 

  6. Bishop JF, McGrath K, Wolf MM, Mathews JP, De Luise T, Holdsworth R, Yuen K, Veale M, Whiteside MG, Cooper IA, Szer J: Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 71:383, 1988

    PubMed  CAS  Google Scholar 

  7. Bodey GP, Buckley M, Sather YS, Freireich EJ: Quantitative relationships between circulating leukocytes and infections in patients with acute leukemia.Ann Intern Med 64:328, 1966

    CAS  Google Scholar 

  8. Butler TP, Gullino PM: Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Research 35:512, 1975

    PubMed  CAS  Google Scholar 

  9. Button LN, DeWolf WC, Newburger PE, Jacobson MS, Kevy SV: The effects of irradiation on blood components. Transfusion 21:419, 1981

    Article  PubMed  CAS  Google Scholar 

  10. Cavins JA, Farber S, and Roy AJ: Transfusion of fresh platelet concentrates to adult patients with thrombocytopenia. Transfusion 8:24, 1968

    Article  PubMed  CAS  Google Scholar 

  11. Cimo PL, Aster RH: Post-transfusion purpura. N Engl J Med 287:290, 1972

    Article  PubMed  CAS  Google Scholar 

  12. Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD: Granulocyte transfusions for the prevention of infection in patients receiving bone marrow transplants. N Engl J Med 298:1052, 1978

    Article  PubMed  CAS  Google Scholar 

  13. Cohen D, Weinstein H, Mihm M, Yankee R: Nonfatal graftversus-host disease occurring after transfusion with leukocytes and platelets obtained from normal donors. Blood 53:1053, 1979

    PubMed  CAS  Google Scholar 

  14. Conrad ME: Disease transmissible by blood transfusion: viral hepatitis and other infectious disorders. Seminars in Hematology 18:122, 1981

    PubMed  CAS  Google Scholar 

  15. Curran JW, Lawrence DN, Jaffe H, Kaplan JE, Zyla LD, Chamberland M, Weinstein R, Lui KJ, Schonberger LB, Spira TJ, Alexander WJ, Swinger G, Ammann A, Solomon S, Auerbach D, Mildvan D, Stoneburner R, Jason JM, Haverkos HW, Evatt BL: Acquired immunodeficiency syndrome (AIDS) associated with transfusions. NEngl Med 310 69–984

    Google Scholar 

  16. Dinsmore RE, Straus DJ, Pollack MS, Woodruff JM, Garrett TJ, Young CW, Clarkson BD, Dupont B: Fatal-graft-versushost disease following blood transfusion in Hodgkin’s disease documented by HLA typing. Blood 55;831, 19XX

    Google Scholar 

  17. Djerassi I, Kim JS, Suvansi J: Filtration leukopheresis: principles and techniques of harvesting and transfusion of filtered granulocytes and monocytes. Proceedings of the International Symposium on Leukocyte Separation and Transfusions. London, England, New York, Academic Press, 1974

    Google Scholar 

  18. Duke WW: The relation of blood platelets to hemorrhagic disease: descriptive of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. JAMA 55:1185, 1910

    Google Scholar 

  19. Eys JV, Thomas D, Olivos B: Platelet use in pediatric oncology: a review of 393 transfusions. Transfusion 18:169, 1978

    Article  PubMed  Google Scholar 

  20. Feinstone SM, Kapikian AZ, Purcell RH, Alater HJ, Holland PV: Transfusion-associated hepatitis not due to viral hepatitis type A or B.N Engl J Med 292:767, 1975

    Article  CAS  Google Scholar 

  21. Ford JM, Cullen, MH, Lucey JJ, Tobias JS, Lister TA: Fatalgraft-versus-host disease following transfusion of granulocytes from normal donors. Lancet 1167, 1976

    Google Scholar 

  22. Fortuny IE, Bloomfield CD, Hadlock DC, Goldman A, Kennedy BJ, McCullough JJ: Granulocyte transfusion: a controlled study in patients with acute nonlymphocytic leukemia. Transfusion 15:548, 1975

    Article  PubMed  CAS  Google Scholar 

  23. Freireich EJ: Effectiveness of platelet transfusion in leukemia and aplastic anemia. Transfusion 6:50, 1966

    Article  Google Scholar 

  24. Freireich EJ, Kliman A, Gaydos LA, Mantel N, Frei E: Response to repeated platelet transfusion from the same donor. Ann Intern Med 59:277,1963

    PubMed  CAS  Google Scholar 

  25. Gaydos LA, Freireich EJ, Mantel N: The quantitative relation between platelet count and hemorrhage in patients with acute leukemia.N Engl J Med 266:905, 1962

    Article  CAS  Google Scholar 

  26. Gmur J, von Felten A, Osterwalder B, Honegger H, Hormann A, Sauter C, Deubelbeiss K, Berchtold W, Metaxas M, Scali G, Frick PG: Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia. Blood 62:473, 1983

    PubMed  CAS  Google Scholar 

  27. Goldfinger D: Acute hemolytic transfusion reactions - a fresh look at pathogenesis and considerations regarding therapy. Transfusion 17:85, 1977

    Article  PubMed  CAS  Google Scholar 

  28. Graw RG Jr, Herzig G, Perry S, Henderson ES: Normal granulocyte transfusion therapy of septicemia due to gram-negative bacteria. N Engl J Med 287:367, 1972

    Article  PubMed  Google Scholar 

  29. Harker LA, Slichter SH: The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 287:155, 1972

    Article  PubMed  CAS  Google Scholar 

  30. Heal JM, Blumberg N, Masel D: An evaluation of cross-matching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood 70:23, 1987

    PubMed  CAS  Google Scholar 

  31. Heinrich D, Mueller-Eckhardt C, Stier W: The specificity of leukocyte and platelet alloantibodies in sera of patients with non-hemolytic transfusion reactions. Vox Sang 25:442, 1973

    Article  PubMed  CAS  Google Scholar 

  32. Hersh EM et al.: Causes of death in acute leukemia. JAMA 193:105, 1965

    PubMed  CAS  Google Scholar 

  33. Herzig RH, Herzig GP, Bull MI, Decter JA, Lohrmann HP, Stout F, Yankee RA, Graw RG Jr: Correction of poor platelet transfusion responses with leukocyte-poor HLA-A-matched platelet concentrates. Blood 46:743, 1975

    PubMed  CAS  Google Scholar 

  34. Herzig RH, Herzig GP, Graw RG Jr, Bull MI, Ray KK: Successful granulocyte transfusion therapy for gram-negative septicemia. N Engl J Med 296:701, 1977

    Article  PubMed  CAS  Google Scholar 

  35. Higby DJ, Burnett D: Granulocyte transfusions: current status. Blood 55:2, 1980

    PubMed  CAS  Google Scholar 

  36. Higby DJ, Cohen E, Holland JF, Sinks L: The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion 14:440, 1974

    Article  PubMed  CAS  Google Scholar 

  37. Higby DJ, Yates JW, Henderson ES, Holland JF: Filtration leukopheresis for granulocyte transfusion therapy. N Engl J Med 292:761, 1975

    Article  PubMed  CAS  Google Scholar 

  38. Holt PDJ, Tandy NP, Anstee DJ: Screening of blood donors for IgA deficiency: a study of the donor population of South-West England. J Clin Path 30:1007, 1977

    Article  PubMed  CAS  Google Scholar 

  39. Huestis DW: Anti-IgA in blood donors. Transfusion 16:289, 1976

    Article  Google Scholar 

  40. Hutchin P: History of blood transfusion: a tercentennial look. Surgery 64:685, 1968

    PubMed  CAS  Google Scholar 

  41. Koistinen J: Selective IgA deficiency in blood donors. Vox Sang 29:192, 1975

    Article  PubMed  CAS  Google Scholar 

  42. Lee EJ, Schiffer CA: Serial measurement of lymphocytotoxic antibody and response to nonmatched platelet transfusions in alloimmunized patients. Blood 70:1727, 1987

    PubMed  CAS  Google Scholar 

  43. Liotta LA, Kleinerman J, Saidel GM: The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Research 36:889, 1976

    PubMed  CAS  Google Scholar 

  44. Lohrmann HP, Bull MI, Decter JA, Yankee RA, Graw RG: Platelet transfusions from HL-A compatible unrelated donors to alloimmunized patients. Ann Intern Med 80:9, 1974

    PubMed  CAS  Google Scholar 

  45. McCredie KB, Freireich EJ, Hester JP: Leukocyte transfusion therapy for patients with host-defense failure. Transplant Proc 5:1285, 1973

    PubMed  CAS  Google Scholar 

  46. Meltz DJ, David DS, Bertles JF, deCiutiis AC: Delayed hemolytic transfusion reactions with renal failure. Lancet 1348, 1971

    Google Scholar 

  47. Moore SB, Taswell HF, Pinedia AA, Sonnenberg CL: Delayed hemolytic transfusion reactions. Amer Jour Clin Path 74:94, 1980

    CAS  Google Scholar 

  48. Morse EE, Freireich EJ, Carbone PP: The transfusion of leukocytes from donors with chronic myelocytic leukemia to patients with leukopenia. Transfusion 6:183, 1966

    Article  Google Scholar 

  49. Murphy S, Koch PA, Evans AE: Randomized trial of prophylactic vs. therapeutic platelet transfusion in childhood acute leukemia. Clin Research 24:379A, 1976

    Google Scholar 

  50. Myhre BA: Fatalities from blood transfusion.JAMA 244:1333, 1980

    CAS  Google Scholar 

  51. National Institutes of Health Consensus Development Conference Statement: Perioperative Red Cell Transfusion. Vol. 7, Number 4, June 27–29, 1988

    Google Scholar 

  52. O’Donnell I, Nowicki B, Hill LR: Prevention of refractoriness using filtered blood products. Blood 71:1402, 1988

    PubMed  Google Scholar 

  53. Parkman R, Mosier D, Umansky I, Cochran W, Carpenter CB, Rosen FS: Graft versus host disease after intrauterine and exchange transfusion for hemolytic disease of the newborn. N Engl J Med 290:359, 1974

    Article  PubMed  CAS  Google Scholar 

  54. Parpat AK: Whole blood preservation. J Clin Invest 26:641, 1947

    Article  Google Scholar 

  55. Pineda AA, Brzica SM, Taswell HF Jr: Hemolytic transfusion reaction, recent experience in a large blood bank. Mayo Clin Proc 53:378, 1978

    PubMed  CAS  Google Scholar 

  56. Pineda AA, Taswell HF, Brzica SM Jr: Delayed hemolytic transfusion reaction, an immunologic hazard of blood transfusion. Transfusion 18:1, 1978

    Article  PubMed  CAS  Google Scholar 

  57. Rabiner SF, Helbert JR, Lopas H, Friedman LH: Evaluation of stroma-free hemoglobin solution for use as a plasma expander. J Exp Mex 126:1127, 1967

    Article  CAS  Google Scholar 

  58. Relihan M, Litwin MS: Effects of stroma free hemoglobin solution on clearance rate and renal function. Surgery 71:395, 1972

    PubMed  CAS  Google Scholar 

  59. Rosen RC, Huestis DW, Corrigan JJ Jr: Acute leukemia and granulocyte transfusion: fatal graft-versus-host reaction following transfusion of cells obtained from normal donors. Journ Ped 93:268,1978

    Article  CAS  Google Scholar 

  60. Roy AJ, Jaffe N, Djerassi J: Prophylactic platelet transfusions in children with acute leukemia: a dose response study. Transfusion 13:283, 1973

    Article  PubMed  CAS  Google Scholar 

  61. Schiffer CA, Aisner J, Daly PA, Schimpff SC, Wiernik PH: Alloimmunization following prophylactic granulocyte transfusion. Blood 54:766, 1979

    PubMed  CAS  Google Scholar 

  62. Schmidt PJ, Holland PV: Pathogenesis of the acute renal failure associated with incompatible transfusion. Lancet 2:1169, 1967

    Article  PubMed  CAS  Google Scholar 

  63. Shulman NR, Aster RH, Leitner A et al.: Immunoreactions involving platelets. Post-transfusion purpura due to a complement-fixing antibody against genetically controlled platelet antigen: a proposed mechanism for thrombocytopenia and its relevance in “autoimmunity” J Clin Invest 40:1597, 1961

    Article  PubMed  CAS  Google Scholar 

  64. Shulman NR: Immunological considerations attending platelet transfusion. Transfusion 6:39, 1966

    Article  Google Scholar 

  65. Slichter SJ: Controversies in platelet transfusion therapy. Ann Rev Med 31:509, 1980

    Article  CAS  Google Scholar 

  66. Slichter SJ, Harker LA: Hemostasis in malignancy. Ann NY Acad Sci 230:252, 1974

    Article  PubMed  CAS  Google Scholar 

  67. Slichter SJ, Harker LA: Thrombocytopenia: mechanisms and management of defects in platelet production. Clinics in Haematology 7:523, 1978

    PubMed  CAS  Google Scholar 

  68. Van Prooijen HC, Riemens TI, Akkerman JW: Clinical experience with transfusion of leukocyte-poor platelet concentrates prepared by filtration with prostacyclin. Blood 70:243, 1987

    PubMed  Google Scholar 

  69. Vogler WR, Winton EV: A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia.Am J Med 63:548, 1977

    CAS  Google Scholar 

  70. Vyas GN, Perkins HA, Yang YM, Basantani GK: Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA. J Lab Clin Med 85:838, 1975

    PubMed  CAS  Google Scholar 

  71. Ward HN: Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 73:689, 1970

    PubMed  CAS  Google Scholar 

  72. Weisberg JL, Linker CA: Prednisone therapy of post-transfusion purpura. Ann Intern Med 100:76, 1984

    PubMed  CAS  Google Scholar 

  73. Winston DJ, Ho WG, Gale RP: Prophylactic granulocyte transfusions during chemotherapy of acute non-lymphocytic leukemia. Ann Intern Med: 94:616, 1981

    PubMed  CAS  Google Scholar 

  74. Wintrobe MM, Lee GR, Boggs DR, Bithel TC, Foerster J, Athens JW, Lukens JN: Clinical Hematology Eighth Edition, Philadelphia, Lea & Febiger, 1981

    Google Scholar 

  75. Yankee RA, Grumet FC, Rogentine GN: Platelet transfusion therapy. N Engl J Med 281:1208, 1969

    Article  PubMed  CAS  Google Scholar 

  76. Yankee RA, Graff KS, Dowling R, Henderson ES: The selection of unrelated compatible platelet donors by lymphocyte HL-A matching.N Eng J Med 288:760, 1973

    Article  CAS  Google Scholar 

  77. Zeigler Z, Murphy S, Gardner FH: Post-transfusion purpura: a heterogeneous syndrome. Blood 45:529, 1975

    PubMed  CAS  Google Scholar 

  78. Zeigler ZR, Shadduck RK, Rosenfeld CS, Mangan KF, Winklestein A, Oral A, Ramsey GE, Duquesnoy RJ: High-dose intravenous gamma globulin improves responses to single-donor platelets in patients refractory to platelet transfusion. Blood 70:1433, 1987

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. John C. Phares
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Oncology, Vincent T. Lombardi Cancer Research Center, Georgetown University School of Medicine, Washington, D.C., USA

    Paul V. Woolley

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Phares, J.C. (1989). Hematologic Support of the Patient with Malignancy. In: Woolley, P.V. (eds) Cancer Management in Man. Cancer Growth and Progression, vol 10. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1095-9_17

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1095-9_17

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6983-0

  • Online ISBN: 978-94-009-1095-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation